Alexion Pharmaceuticals Inc (NASDAQ:ALXN) over-valued by 11%
| Website | https://alexion.com/ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $37,614,854,144 |
| Beta | 1.27027 |
| Average Volume | $2,428,403 |
| Last Dividend | 0% |
| Price on Feb 8, 2021 | $170.27 |
| Autochartist™ Valuation | $152.38 |
| Conclusion |
11% over-valued |
| Download Report |
